Clinical Trial Update: Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing renal artery denervation in addition to catheter ablation for atrial fibrillation, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Hypertension

Drugs mentioned

• Renal artery denervation in addition to catheter ablation

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Atrial Fibrillation, Hypertension | Phase 3 | Status: COMPLETED